Clinical Trial Update: Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating AVE8062 in combination with docetaxel in patients with advanced solid tumors, focusing on safety and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AVE8062
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Advanced Neoplastic Disease | Phase 1 | Status: COMPLETED